$SWBI
SMITH & WESSON BRANDS, INC.

2023 Q2 Form 10-K Financial Statement

#000095017023029412 Filed on June 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023
Revenue $144.8M $479.2M
YoY Change -20.15% -44.54%
Cost Of Revenue $102.2M $324.7M
YoY Change -6.32% -33.67%
Gross Profit $42.60M $154.5M
YoY Change -41.02% -58.74%
Gross Profit Margin 29.43% 32.25%
Selling, General & Admin $20.57M $98.58M
YoY Change -12.77% -14.76%
% of Gross Profit 48.29% 63.79%
Research & Development $1.875M $7.550M
YoY Change -5.92% 3.97%
% of Gross Profit 4.4% 4.89%
Depreciation & Amortization $9.641M $31.44M
YoY Change 25.86% 4.53%
% of Gross Profit 22.63% 20.34%
Operating Expenses $22.45M $106.1M
YoY Change -12.23% -13.65%
Operating Profit $20.16M $48.41M
YoY Change -56.8% -80.76%
Interest Expense $1.030M -$331.0K
YoY Change -294.34% -84.5%
% of Operating Profit 5.11% -0.68%
Other Income/Expense, Net -$2.154M -$181.0K
YoY Change -445.19% -124.69%
Pretax Income $16.70M $48.23M
YoY Change -64.27% -80.89%
Income Tax $3.867M $11.35M
% Of Pretax Income 23.15% 23.54%
Net Earnings $12.84M $36.88M
YoY Change -64.47% -81.04%
Net Earnings / Revenue 8.87% 7.69%
Basic Earnings Per Share $0.80
Diluted Earnings Per Share $0.28 $0.80
COMMON SHARES
Basic Shares Outstanding 46.08M 45.84M
Diluted Shares Outstanding 46.17M

Balance Sheet

Concept 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.56M $53.56M
YoY Change -55.64% -55.64%
Cash & Equivalents $53.56M $53.56M
Short-Term Investments
Other Short-Term Assets $4.917M $4.917M
YoY Change -11.71% -11.71%
Inventory $177.1M $177.1M
Prepaid Expenses
Receivables $55.15M $55.15M
Other Receivables $1.176M $1.176M
Total Short-Term Assets $291.9M $291.9M
YoY Change -10.89% -10.89%
LONG-TERM ASSETS
Property, Plant & Equipment $212.2M $212.2M
YoY Change 52.5% 52.5%
Goodwill $19.02M
YoY Change 0.0%
Intangibles $3.588M
YoY Change -0.55%
Long-Term Investments
YoY Change
Other Assets $8.347M $14.59M
YoY Change -20.01% 79.67%
Total Long-Term Assets $249.4M $249.4M
YoY Change 46.8% 46.8%
TOTAL ASSETS
Total Short-Term Assets $291.9M $291.9M
Total Long-Term Assets $249.4M $249.4M
Total Assets $541.3M $541.3M
YoY Change 8.81% 8.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $36.80M $36.80M
YoY Change 22.48% 22.48%
Accrued Expenses $43.45M $43.45M
YoY Change -9.6% -9.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.434M $1.434M
YoY Change 23.83% 23.83%
Total Short-Term Liabilities $87.21M $87.21M
YoY Change -1.95% -1.95%
LONG-TERM LIABILITIES
Long-Term Debt $61.75M $61.75M
YoY Change 64.11% 64.11%
Other Long-Term Liabilities $7.707M $7.707M
YoY Change -25.79% -25.79%
Total Long-Term Liabilities $7.707M $69.46M
YoY Change -25.79% 44.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.21M $87.21M
Total Long-Term Liabilities $7.707M $69.46M
Total Liabilities $156.7M $156.7M
YoY Change 14.39% 14.39%
SHAREHOLDERS EQUITY
Retained Earnings $523.2M
YoY Change 3.67%
Common Stock $283.7M
YoY Change 2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $422.4M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $384.6M $384.6M
YoY Change
Total Liabilities & Shareholders Equity $541.3M $541.3M
YoY Change 8.81% 8.81%

Cashflow Statement

Concept 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $12.84M $36.88M
YoY Change -64.47% -81.04%
Depreciation, Depletion And Amortization $9.641M $31.44M
YoY Change 25.86% 4.53%
Cash From Operating Activities $37.98M $16.73M
YoY Change 48.71% -87.86%
INVESTING ACTIVITIES
Capital Expenditures $25.06M $89.57M
YoY Change -380.12% 273.62%
Acquisitions
YoY Change
Other Investing Activities $33.00K $118.0K
YoY Change -21.43% -15.11%
Cash From Investing Activities -$25.03M -$89.78M
YoY Change 181.07% 272.29%
FINANCING ACTIVITIES
Cash Dividend Paid $18.33M
YoY Change 21.94%
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -3.991M 5.877M
YoY Change 25.74% -105.55%
NET CHANGE
Cash From Operating Activities 37.98M 16.73M
Cash From Investing Activities -25.03M -89.78M
Cash From Financing Activities -3.991M 5.877M
Net Change In Cash 8.960M -67.17M
YoY Change -33.43% -971.12%
FREE CASH FLOW
Cash From Operating Activities $37.98M $16.73M
Capital Expenditures $25.06M $89.57M
Free Cash Flow $12.92M -$72.83M
YoY Change -62.54% -163.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001092796
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
CY2022 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2023Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#FinanceLeaseLiabilityNoncurrent
CY2023Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2022Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.smith-wesson.com/20230430#AccruedExpensesAndDeferredRevenueCurrent
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.00083
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
1-31552
CY2023 dei Entity Registrant Name
EntityRegistrantName
Smith & Wesson Brands, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0543688
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Roosevelt Avenue
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Springfield
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01104
CY2023 dei City Area Code
CityAreaCode
800
CY2023 dei Local Phone Number
LocalPhoneNumber
331-0852
CY2023 dei Security12b Title
Security12bTitle
Common Stock, Par Value $.001 per Share
CY2023 dei Trading Symbol
TradingSymbol
SWBI
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
510424727
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46082706
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
Hartford, CT, USA
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53556000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120728000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
36000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55153000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62695000
CY2023Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
177118000
CY2022Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
136660000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4917000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5569000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1176000
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1945000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
291920000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
327597000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
210330000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
135591000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3588000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3608000
CY2023Q2 us-gaap Goodwill
Goodwill
19024000
CY2022Q2 us-gaap Goodwill
Goodwill
19024000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8085000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1221000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8347000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10435000
CY2023Q2 us-gaap Assets
Assets
541294000
CY2022Q2 us-gaap Assets
Assets
497476000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
36795000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30042000
CY2023Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
20149000
CY2022Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
23482000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18565000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17371000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1831000
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2673000
CY2023Q2 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
8203000
CY2022Q2 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
13543000
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1670000
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1838000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
87213000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
88949000
CY2023Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
24790000
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
36961000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
37628000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7707000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10385000
CY2023Q2 us-gaap Liabilities
Liabilities
156671000
CY2022Q2 us-gaap Liabilities
Liabilities
136962000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75029300
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45988930
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74641439
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45601069
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
75000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
283666000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
278101000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
523184000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
504640000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
73000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
73000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29040370
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29040370
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
422375000
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
422375000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
384623000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
360514000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
541294000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
497476000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
479242000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
864126000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1059195000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
324705000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
489562000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
610212000
CY2023 us-gaap Gross Profit
GrossProfit
154537000
CY2022 us-gaap Gross Profit
GrossProfit
374564000
CY2021 us-gaap Gross Profit
GrossProfit
448983000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7550000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7262000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7480000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36976000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
43156000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
42603000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61604000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
72493000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
79268000
CY2023 us-gaap Operating Expenses
OperatingExpenses
106130000
CY2022 us-gaap Operating Expenses
OperatingExpenses
122911000
CY2021 us-gaap Operating Expenses
OperatingExpenses
129351000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
48407000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
251653000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
319632000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2868000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2252000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-331000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2135000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3919000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-181000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
733000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1667000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48226000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
252386000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
317965000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11350000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57892000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74394000
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
36876000
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
194494000
CY2023 us-gaap Dividends
Dividends
18333000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
243571000
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2021 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
8478000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
36876000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
194494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
252049000
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.80
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.12
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.46
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.62
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.80
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.08
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.40
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.08
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.55
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45844000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47227000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54613000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46170000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47728000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55352000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
387118000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1540000
CY2021 swbi Adjustments To Additional Paid In Capital Share Based Compensation Continuing Operations Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationContinuingOperationsRequisiteServicePeriodRecognitionValue
4706000
CY2021 swbi Adjustments To Additional Paid In Capital Share Based Compensation Discontinued Operations Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDiscontinuedOperationsRequisiteServicePeriodRecognitionValue
184000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1614000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2243000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
110000000
CY2021 us-gaap Dividends
Dividends
8223000
CY2021 swbi Adjustments To Additional Paid In Capital Spin Off Of Outdoor Products And Accessories
AdjustmentsToAdditionalPaidInCapitalSpinOffOfOutdoorProductsAndAccessories
-260361000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
252049000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
266384000
CY2022 swbi Adjustments To Additional Paid In Capital Share Based Compensation Continuing Operations Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationContinuingOperationsRequisiteServicePeriodRecognitionValue
4536000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1719000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1584000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
90000000
CY2022 us-gaap Dividends
Dividends
15035000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
194494000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
360514000
CY2023 swbi Adjustments To Additional Paid In Capital Share Based Compensation Continuing Operations Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationContinuingOperationsRequisiteServicePeriodRecognitionValue
5102000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1528000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1065000
CY2021 swbi Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
-24633000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
36876000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
384623000
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
36876000
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
194494000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
243571000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31436000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30073000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31575000
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
55000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-625000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-154000
CY2023 swbi Provision For Or Recoveries Of Doubtful Accounts
ProvisionForOrRecoveriesOfDoubtfulAccounts
-27000
CY2022 swbi Provision For Or Recoveries Of Doubtful Accounts
ProvisionForOrRecoveriesOfDoubtfulAccounts
689000
CY2021 swbi Provision For Or Recoveries Of Doubtful Accounts
ProvisionForOrRecoveriesOfDoubtfulAccounts
-739000
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
86000
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6864000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2125000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
447000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5102000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4536000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4706000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7569000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4058000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5824000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40458000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58183000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25264000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-653000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2839000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
852000
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
74000
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-480000
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3643000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8606000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26957000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25540000
CY2023 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
1194000
CY2022 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-10000
CY2021 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
4933000
CY2023 swbi Increase Decrease In Deferred Profit Sharing
IncreaseDecreaseInDeferredProfitSharing
-5340000
CY2022 swbi Increase Decrease In Deferred Profit Sharing
IncreaseDecreaseInDeferredProfitSharing
-902000
CY2021 swbi Increase Decrease In Deferred Profit Sharing
IncreaseDecreaseInDeferredProfitSharing
12248000
CY2023 swbi Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
-3618000
CY2022 swbi Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
-9725000
CY2023 swbi Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
-168000
CY2022 swbi Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
-361000
CY2021 swbi Increase Decrease In Product Warranty Accrual
IncreaseDecreaseInProductWarrantyAccrual
-1098000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1789000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2561000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1579000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2677000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4364000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
4032000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16732000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
137814000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
317260000
CY2023 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0
CY2021 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1926000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16732000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
137814000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
315334000
CY2023 swbi Proceeds From Refunds On Machinery And Equipment
ProceedsFromRefundsOnMachineryAndEquipment
0
CY2022 swbi Proceeds From Refunds On Machinery And Equipment
ProceedsFromRefundsOnMachineryAndEquipment
0
CY2021 swbi Proceeds From Refunds On Machinery And Equipment
ProceedsFromRefundsOnMachineryAndEquipment
310000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
334000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
283000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
632000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
118000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
139000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
113000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89565000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23972000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22052000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-89781000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24116000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-22261000
CY2021 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-1143000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89781000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24116000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23404000
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000000
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
450000
CY2023 swbi Repayments Of Long Term On Finance Lease Obligation
RepaymentsOfLongTermOnFinanceLeaseObligation
1253000
CY2022 swbi Repayments Of Long Term On Finance Lease Obligation
RepaymentsOfLongTermOnFinanceLeaseObligation
1087000
CY2021 swbi Repayments Of Long Term On Finance Lease Obligation
RepaymentsOfLongTermOnFinanceLeaseObligation
996000
CY2022 swbi Machinery And Equipment On Deposit Placed Into Service
MachineryAndEquipmentOnDepositPlacedIntoService
0
CY2021 swbi Machinery And Equipment On Deposit Placed Into Service
MachineryAndEquipmentOnDepositPlacedIntoService
1855000
CY2023 swbi Capital Lease Included In Accrued Expenses And Finance Lease Payable
CapitalLeaseIncludedInAccruedExpensesAndFinanceLeasePayable
767000
CY2022 swbi Capital Lease Included In Accrued Expenses And Finance Lease Payable
CapitalLeaseIncludedInAccruedExpensesAndFinanceLeasePayable
0
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
185000000
CY2023 swbi Distribution To Discontinued Operations
DistributionToDiscontinuedOperations
0
CY2022 swbi Distribution To Discontinued Operations
DistributionToDiscontinuedOperations
0
CY2021 swbi Distribution To Discontinued Operations
DistributionToDiscontinuedOperations
25000000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
90000000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
110000000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
18333000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
15035000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
8223000
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1528000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1719000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3154000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1065000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1584000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2243000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5877000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-105987000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-303758000
CY2023 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2022 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
CY2021 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-166000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5877000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-105987000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-303924000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67172000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7711000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11994000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120728000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
113017000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
125011000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53556000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120728000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
113017000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
2148000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2219000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
3306000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
18208000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
59183000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
80874000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
15767000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
408000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
746000
CY2023 swbi Machinery And Equipment On Deposit Placed Into Service
MachineryAndEquipmentOnDepositPlacedIntoService
0
CY2021 swbi Capital Lease Included In Accrued Expenses And Finance Lease Payable
CapitalLeaseIncludedInAccruedExpensesAndFinanceLeasePayable
0
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Organization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We are one of the world’s leading manufacturers and designers of firearms. We manufacture a wide array of handguns (including revolvers and pistols), long guns (including modern sporting rifles), handcuffs, firearm suppressors, and other firearm-related products for sale to a wide variety of customers, including firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement and security agencies and officers, and military agencies in the United States and throughout the world. We sell our products under the Smith &amp; Wesson, M&amp;P, and Gemtech brands. We manufacture our products at our facilities in Springfield, Massachusetts; Houlton, Maine; and Deep River, Connecticut. We also sell our manufacturing services to other businesses to attempt to level-load our factories. We sell those services under our Smith &amp; Wesson and Smith &amp; Wesson Precision Components brands. We plan to move our headquarters and certain of our manufacturing operations to a new facility being constructed in Maryville. See Note 16 — </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Commitments and Contingencies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, for more information regarding this plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On November 13, 2019, we announced that we were proceeding with a plan to spin-off our outdoor products and accessories business and create an independent publicly traded company to conduct that business, or the Separation. On August 24, 2020, or the Distribution Date, we completed the Separation. See also Note 3 — </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Discontinued Operations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, for more information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> — The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the financial statement dates and the reported amounts of revenue and expenses during the reporting periods. Our significant estimates include the accrual for warranty, reserves for excess and obsolete inventory, rebates and other promotions, valuation of intangible assets, and costs associated with the Relocation. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 swbi Cash And Cash Equivalent Maturity Period Maximum
CashAndCashEquivalentMaturityPeriodMaximum
P3M
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> — Financial instruments that potentially subject us to concentration of credit risk consist principally of cash, cash equivalents, and trade receivables. We place our cash and cash equivalents in overnight U.S. government securities. Concentrations of credit risk with respect to trade receivables are limited by the large number of customers comprising our customer base and their geographic and business dispersion. We perform ongoing credit evaluations of our customers’ financial condition and generally do not require collateral.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For fiscal 2023, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of our customers each accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our net sales, totaling </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our net sales. As of April 30, 2023, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of our customers each accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our accounts receivable, for a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. For fiscal 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customer accounted for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our net sales. As of April 30, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of our customers each accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our accounts receivable, for a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. For fiscal 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of our customers each accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our net sales, totaling </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our net sales. As of April 30, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of these customers each accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our accounts receivable, for a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%.</span></p>
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
36876000
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
194494000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
243571000
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
8478000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
36876000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
194494000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
252049000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45844000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47227000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54613000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
326000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
501000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
739000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46170000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47728000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55352000
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.80
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.12
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.46
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.16
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.62
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.80
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.08
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.40
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.15
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.08
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.55
CY2023 swbi Shares Excluded From The Computation Of Diluted Earnings Per Share
SharesExcludedFromTheComputationOfDilutedEarningsPerShare
30307
CY2022 swbi Shares Excluded From The Computation Of Diluted Earnings Per Share
SharesExcludedFromTheComputationOfDilutedEarningsPerShare
43530
CY2021 swbi Shares Excluded From The Computation Of Diluted Earnings Per Share
SharesExcludedFromTheComputationOfDilutedEarningsPerShare
9301
CY2022Q1 us-gaap Goodwill
Goodwill
19000000.0
CY2023 swbi Future Estimated Recall Costs
FutureEstimatedRecallCosts
40000
CY2023 us-gaap Product Warranty Expense
ProductWarrantyExpense
1500000
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
1900000
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
5200000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5693000
CY2022 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1910000
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2730000
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4873000
CY2023 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1496000
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2364000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4005000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2075000
CY2023Q2 swbi Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
41631000
CY2023Q2 swbi Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
9448000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
32183000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
10200000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
6600000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
10500000
CY2023 us-gaap Cooperative Advertising Expense
CooperativeAdvertisingExpense
2700000
CY2022 us-gaap Cooperative Advertising Expense
CooperativeAdvertisingExpense
4300000
CY2021 us-gaap Cooperative Advertising Expense
CooperativeAdvertisingExpense
15200000
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one share of AOUT common stock for every four shares of our common
CY2023Q2 swbi Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
5994000
CY2023Q2 swbi Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
4153000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1841000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1274000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
801000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1434000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
36961000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
38395000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1600000
CY2023 swbi Short Term Operating Lease Cost
ShortTermOperatingLeaseCost
99000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2200000
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1900000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P15Y3M18D
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.050
CY2022Q3 swbi Percentage Of Sublease
PercentageOfSublease
0.647
CY2023 us-gaap Sublease Income
SubleaseIncome
2300000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
2435000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
3180000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
3235000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
3292000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
3350000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
38906000
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
54398000
CY2023Q2 swbi Sublease Receipts Amounts Representing Interest
SubleaseReceiptsAmountsRepresentingInterest
16989000
CY2023Q2 swbi Present Value Of Sublease Receipts
PresentValueOfSubleaseReceipts
37409000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1381000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
3323000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due Year One
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
4704000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
324000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
3378000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due Year Two
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
3702000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
301000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
3433000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due Year Three
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
3734000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
272000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3490000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due Year Four
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
3762000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
125000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
3416000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due Year Five
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFive
3541000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2023Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
38906000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due After Fifth Year
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueAfterFifthYear
38906000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2403000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
55946000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
58349000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
328000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
17551000
CY2023Q2 swbi Lessee Operating And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
17879000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2075000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
38395000
CY2023Q2 swbi Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
40470000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1274000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1434000
CY2023Q2 swbi Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
2708000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
801000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
36961000
CY2023Q2 swbi Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
37762000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
4800000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
89560
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
89560
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
890553
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
479242000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
864126000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1059195000
CY2023 swbi Export Sales As Percentage Of Revenue
ExportSalesAsPercentageOfRevenue
0.04
CY2022 swbi Export Sales As Percentage Of Revenue
ExportSalesAsPercentageOfRevenue
0.03
CY2021 swbi Export Sales As Percentage Of Revenue
ExportSalesAsPercentageOfRevenue
0.02
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
308852000
CY2022Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
299318000
CY2023Q2 swbi Computer Hardware And Software Gross
ComputerHardwareAndSoftwareGross
49569000
CY2022Q2 swbi Computer Hardware And Software Gross
ComputerHardwareAndSoftwareGross
47918000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
40131000
CY2022Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
38552000
CY2023Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
2945000
CY2022Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
2817000
CY2023Q2 swbi Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
41631000
CY2022Q2 swbi Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
40986000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
443128000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
429591000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
334383000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
306350000
CY2023Q2 swbi Property Plant And Equipment And Finance Lease Right Of Use Asset Excluding Construction In Progress
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingConstructionInProgress
108745000
CY2022Q2 swbi Property Plant And Equipment And Finance Lease Right Of Use Asset Excluding Construction In Progress
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingConstructionInProgress
123241000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
101585000
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12350000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
210330000
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
135591000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31436000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30073000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31575000
CY2023Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
6600000
CY2022Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
5600000
CY2023Q2 swbi Workers Compensation Receivable
WorkersCompensationReceivable
663000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93705000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
58460000
CY2023Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
65460000
CY2022Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
62187000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6821000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5304000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11132000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10709000
CY2023Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
177118000
CY2022Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
136660000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4597000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3959000
CY2023Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3703000
CY2022Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7008000
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3256000
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3705000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2596000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1997000
CY2023Q2 swbi Accrued Rebates And Promotions Current
AccruedRebatesAndPromotionsCurrent
1649000
CY2022Q2 swbi Accrued Rebates And Promotions Current
AccruedRebatesAndPromotionsCurrent
1243000
CY2023Q2 swbi Accrued Distributor Incentives Current
AccruedDistributorIncentivesCurrent
1640000
CY2022Q2 swbi Accrued Distributor Incentives Current
AccruedDistributorIncentivesCurrent
2917000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1434000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1158000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1274000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1495000
CY2023Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
20149000
CY2022Q2 swbi Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
23482000
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
9200000
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
8700000
CY2023Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
2600000
CY2022Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
3100000
CY2022Q2 swbi Workers Compensation Receivable
WorkersCompensationReceivable
571000
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
8676000
CY2021Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
9469000
CY2023 swbi Self Insurance Reserves Expense
SelfInsuranceReservesExpense
3589000
CY2022 swbi Self Insurance Reserves Expense
SelfInsuranceReservesExpense
719000
CY2023 swbi Self Insurance Reserve Deductions
SelfInsuranceReserveDeductions
3026000
CY2022 swbi Self Insurance Reserve Deductions
SelfInsuranceReserveDeductions
1512000
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
9239000
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
8676000
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
4300000
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3700000
CY2023Q2 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
568000
CY2022Q2 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
895000
CY2023Q2 swbi Receivables From Insurance Carriers Included In Other Assets
ReceivablesFromInsuranceCarriersIncludedInOtherAssets
0
CY2022Q2 swbi Receivables From Insurance Carriers Included In Other Assets
ReceivablesFromInsuranceCarriersIncludedInOtherAssets
1900000
CY2022 swbi Number Of Stock Option Plans
NumberOfStockOptionPlans
2
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
200667
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.70
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200667
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.67
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2900000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5102000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4536000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4706000
CY2023 swbi Share Based Compensation Arrangement By Share Based Payment Award Performance Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod
P3Y
CY2023 swbi Share Based Compensation Arrangement By Share Based Payment Award Performance Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod
P3Y
CY2023 swbi Share Based Compensation Percentage Of Target Award Granted For Calculating Maximum Aggregate Award Of Performance Share
ShareBasedCompensationPercentageOfTargetAwardGrantedForCalculatingMaximumAggregateAwardOfPerformanceShare
2
CY2023 swbi Percentage Of Stock Outperform In Order For Target Award To Vest
PercentageOfStockOutperformInOrderForTargetAwardToVest
0.05
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
4000000.0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
4400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
5900000
CY2023 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
175047
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5100000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4500000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4700000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16259000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
52843000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
64417000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1955000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7174000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
9530000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18214000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
60017000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
73947000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6217000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1889000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
358000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-647000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-236000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
89000
CY2023 swbi Deferred Income Tax Expense Benefit Continuing And Discontinuing Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuingOperations
-6864000
CY2022 swbi Deferred Income Tax Expense Benefit Continuing And Discontinuing Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuingOperations
-2125000
CY2021 swbi Deferred Income Tax Expense Benefit Continuing And Discontinuing Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuingOperations
447000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11350000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57892000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74394000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10127000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
53001000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
66773000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1023000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
5503000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7685000
CY2023 swbi Income Tax Reconciliation Nondeductible Expense Benefit Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseBenefitShareBasedCompensationCost
136000
CY2022 swbi Income Tax Reconciliation Nondeductible Expense Benefit Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseBenefitShareBasedCompensationCost
-749000
CY2021 swbi Income Tax Reconciliation Nondeductible Expense Benefit Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseBenefitShareBasedCompensationCost
-578000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
89000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
118000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
115000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
265000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
300000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
297000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
0
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
195000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
240000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
319000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
501000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11350000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57892000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74394000
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
7495000
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
5187000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
4764000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
4138000
CY2023Q2 swbi Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
3156000
CY2022Q2 swbi Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards
3168000
CY2023Q2 swbi Deferred Tax Lease Liability Operating
DeferredTaxLeaseLiabilityOperating
473000
CY2022Q2 swbi Deferred Tax Lease Liability Operating
DeferredTaxLeaseLiabilityOperating
866000
CY2023Q2 swbi Deferred Tax Assets Environmental And Products Liabilities
DeferredTaxAssetsEnvironmentalAndProductsLiabilities
596000
CY2022Q2 swbi Deferred Tax Assets Environmental And Products Liabilities
DeferredTaxAssetsEnvironmentalAndProductsLiabilities
614000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
477000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
567000
CY2023Q2 swbi Deferred Tax Assets State Bonus Depreciation
DeferredTaxAssetsStateBonusDepreciation
755000
CY2022Q2 swbi Deferred Tax Assets State Bonus Depreciation
DeferredTaxAssetsStateBonusDepreciation
787000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
913000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1111000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1551000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1356000
CY2023Q2 swbi Deferred Tax Assets Section174 Capitalized Rd Expense
DeferredTaxAssetsSection174CapitalizedRDExpense
1549000
CY2022Q2 swbi Deferred Tax Assets Section174 Capitalized Rd Expense
DeferredTaxAssetsSection174CapitalizedRDExpense
0
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
622000
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
973000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22351000
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18767000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3031000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3086000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19320000
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
15681000
CY2023Q2 swbi Deferred Tax Assets Liabilities Right Of Use Assets
DeferredTaxAssetsLiabilitiesRightOfUseAssets
-420000
CY2022Q2 swbi Deferred Tax Assets Liabilities Right Of Use Assets
DeferredTaxAssetsLiabilitiesRightOfUseAssets
-806000
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8847000
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
12049000
CY2023Q2 swbi Deferred Tax Assets Liabilities Intangible Assets
DeferredTaxAssetsLiabilitiesIntangibleAssets
-1581000
CY2022Q2 swbi Deferred Tax Assets Liabilities Intangible Assets
DeferredTaxAssetsLiabilitiesIntangibleAssets
-1186000
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-387000
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-419000
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
11235000
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14460000
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
8085000
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1221000
CY2023 swbi Tax Cuts And Jobs Act Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
0.235
CY2022 swbi Tax Cuts And Jobs Act Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
0.229
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2023 swbi Number Of Product Liability Cases
NumberOfProductLiabilityCases
7
CY2023 swbi Number Of Other Product Liability Claims
NumberOfOtherProductLiabilityClaims
8
CY2022Q1 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
2
CY2023 swbi Defense And Administrative Costs
DefenseAndAdministrativeCosts
988000
CY2022 swbi Defense And Administrative Costs
DefenseAndAdministrativeCosts
729000
CY2021 swbi Defense And Administrative Costs
DefenseAndAdministrativeCosts
606000
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2023Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1600000
CY2022Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
815000
CY2023 us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
176000
CY2022 us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
1200000
CY2021 us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
388000
CY2023Q1 us-gaap Construction Contract Cost Progress Payment Offset
ConstructionContractCostProgressPaymentOffset
114533853
CY2023Q1 swbi Cost Of Machinery And Equipment
CostOfMachineryAndEquipment
160000000.0
CY2023Q1 swbi Cost Of Machinery And Equipment Due Remainder Of Fiscal Year
CostOfMachineryAndEquipmentDueRemainderOfFiscalYear
170000000.0
CY2023Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
0
CY2022Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
0
CY2023 us-gaap Restructuring Charges
RestructuringCharges
8300000
CY2022 us-gaap Restructuring Charges
RestructuringCharges
10200000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
8261000
CY2022 us-gaap Restructuring Charges
RestructuringCharges
10245000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
8261000
CY2022 us-gaap Restructuring Charges
RestructuringCharges
10245000
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
6188000
CY2023 us-gaap Restructuring Costs
RestructuringCosts
7210000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
1598000
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
11800000

Files In Submission

Name View Source Status
0000950170-23-029412-index-headers.html Edgar Link pending
0000950170-23-029412-index.html Edgar Link pending
0000950170-23-029412.txt Edgar Link pending
0000950170-23-029412-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img125868738_0.jpg Edgar Link pending
img125868738_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
swbi-20230430.htm Edgar Link pending
swbi-20230430.xsd Edgar Link pending
swbi-ex10_111d.htm Edgar Link pending
swbi-ex10_112d.htm Edgar Link pending
swbi-ex10_126.htm Edgar Link pending
swbi-ex10_127.htm Edgar Link pending
swbi-ex21_1.htm Edgar Link pending
swbi-ex23_1.htm Edgar Link pending
swbi-ex31_1.htm Edgar Link pending
swbi-ex31_2.htm Edgar Link pending
swbi-ex32_1.htm Edgar Link pending
swbi-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
swbi-20230430_cal.xml Edgar Link unprocessable
swbi-20230430_def.xml Edgar Link unprocessable
swbi-20230430_pre.xml Edgar Link unprocessable
swbi-20230430_lab.xml Edgar Link unprocessable
swbi-20230430_htm.xml Edgar Link completed